Status:
COMPLETED
Performance of RPA-LF for Cutaneous Leishmaniasis
Lead Sponsor:
Centro Internacional de Entrenamiento e Investigaciones Médicas
Collaborating Sponsors:
University of Texas
Conditions:
Cutaneous Leishmaniasis (Diagnosis)
Eligibility:
All Genders
2+ years
Brief Summary
CL is public health in the Americas, diagnostic confirmation is required to start treatment, however current diagnostic methods have several limitations and its access is limited. Technical requireme...
Detailed Description
CL is public health in the Americas with an average of 55,000 cases per year between 2001 - 2018 in 17 countries, which mainly occur in rural areas with an average of 55,000 cases per year between 200...
Eligibility Criteria
Inclusion
- Men or women with 2 years of age and over of any ethnic group
- Ulcerated skin lesions compatible with cutaneous leishmaniasis with two or more weeks of duration
- Approval of informed consent
Exclusion
- Mucosal leishmaniasis
- Clinical presentations of cutaneous leishmaniasis different of ulcerated lesions
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2019
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT04500873
Start Date
February 1 2018
End Date
December 20 2019
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corporación Centro Internacional de entrenamiento e Investigaciónes Médicas
Cali, Valle del Cauca Department, Colombia, 5930